“Yet Dr. Patterson said he had been using standa
Post# of 148279
Read the PR regarding completion of the leronlimab RO by Incelldx in July 2019. Incelldx’s use of other ROs prior to that is not relevant as those were for other companies, not CYDY.
“completion of development of the Receptor Occupancy Test to measure the expression of CCR5 in HIV and tumor cells that are occupied by leronlimab.”